Trial of Intravenous Immune Globulin in Dermatomyositis,The New England Journal of Medicine

当前位置： X-MOL 学术 › N. Engl. J. Med. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Trial of Intravenous Immune Globulin in Dermatomyositis
The New England Journal of Medicine ( IF 96.2 ) Pub Date : 2022-10-06 , DOI: 10.1056/nejmoa2117912
Rohit Aggarwal ₁ , Christina Charles-Schoeman ₁ , Joachim Schessl ₁ , Zsuzsanna Bata-Csörgő ₁ , Mazen M Dimachkie ₁ , Zoltan Griger ₁ , Sergey Moiseev ₁ , Chester Oddis ₁ , Elena Schiopu ₁ , Jiri Vencovský ₁ , Irene Beckmann ₁ , Elisabeth Clodi ₁ , Olga Bugrova ₁ , Katalin Dankó ₁ , Floranne Ernste ₁ , Namita A Goyal ₁ , Marvin Heuer ₁ , Marie Hudson ₁ , Yessar M Hussain ₁ , Chafic Karam ₁ , Nina Magnolo ₁ , Ronald Nelson ₁ , Nataliia Pozur ₁ , Liudmyla Prystupa ₁ , Miklós Sárdy ₁ , Guillermo Valenzuela ₁ , Anneke J van der Kooi ₁ , Tuan Vu ₁ , Margitta Worm ₁ , Todd Levine ₁ ,

Affiliation

From the University of Pittsburgh School of Medicine, Pittsburgh (R.A., C.O.), and Penn Neuroscience Center-Neurology, Hospital of the University of Pennsylvania, Philadelphia (C.K.) - both in Pennsylvania; the University of California, Los Angeles, Los Angeles (C.C.-S.), and the Department of Neurology, University of California, Irvine, Irvine (N.A.G.); the Friedrich-Baur Institute, Department of Neurology (J.S.), and the Department of Dermatology and Allergy, University Hospital (M.S.), Ludwig-Maximilians University of Munich, Munich, the University Hospital of Münster, Münster (N.M.), and the Clinic for Dermatology, Venereology and Allergology, Charité, Universitätsmedizin Berlin, Berlin (M.W.) - all in Germany; the Department of Dermatology and Allergology, University of Szeged, Szeged (Z.B.-C.), the Division of Clinical Immunology, Faculty of Medicine, University of Debrecen, Debrecen (Z.G., K.D.), and the Department of Dermatology, Venereology, and Dermatooncology, Semmelweis University, Budapest (M.S.) - all in Hungary; the University of Kansas Medical Center, Kansas City (M.M.D.); the Tareev Clinic of Internal Diseases, Sechenov First Moscow State Medical University, Moscow (S.M.), and Orenburg State Medical University, Orenburg (O.B.) - both in Russia; the Division of Rheumatology, Department of Internal Medicine, Michigan Medicine University Hospitals, Ann Arbor (E.S.); the Institute of Rheumatology and the Department of Rheumatology, Charles University, Prague, Czech Republic (J.V.); Octapharma Pharmazeutika, Vienna (I.B., E.C.); the Division of Rheumatology, Department of Internal Medicine, Mayo Clinic, Rochester, MN (F.E.); HMD Research, Orlando (M. Heuer), and Integral Rheumatology and Immunology Specialists (IRIS) and IRIS Research and Development, Plantation (G.V.), and the Department of Neurology, University of South Florida, Tampa (T.V.) - all in Florida; the Division of Rheumatology, Department of Medicine, Jewish General Hospital, Lady Davis Institute and McGill University, Montreal (M. Hudson); the University of Texas at Austin Dell Medical School, Austin Neuromuscular Center, Austin (Y.M.H.); Stones River Dermatology, Murfreesboro, TN (R.N.); Ivano-Frankivsk City Clinical Hospital No. 1, Ivano-Frankivsk (N.P.), and the Department of Internal Medicine, Sumy State University, Medical Institute, Sumy (L.P.) - both in Ukraine; the Department of Neurology, Amsterdam University Medical Centers, Amsterdam (A.J.K.); and Phoenix Neurological Associates, Phoenix, AZ (T.L.).

New England Journal of Medicine, Volume 387, Issue 14, Page 1264-1278, October 2022.

中文翻译：